Skip to main content
. 2020 May 8;94(5):1375–1415. doi: 10.1007/s00204-020-02725-2

Table 2.

Selected high-quality developmental toxicity studies

Species, strain, number of animals Exposure duration, chemical form, route NaF
concentration
in DW
(mg/L)
Doses (mg/kg/d) NOAEL
(mg/L)
(mg/kg/d)
LOAEL
(mg/L) (mg/kg/d)
Outcome (as stated by the authors) Comments References
Rat, CD, 26/group

GD 6 through 15

Investigations were done on GD 20

Sodium fluoride (DW)

 < 0.6, 50, 150, 300 NaFa: 0, 6.6, 18.3, 27.1

 ≥ 300 mg/L NaF

27 mg NaF/kg/da

Maternal exposure to NaF during organogenesis did not significantly affect the frequency of postimplantation loss, mean fetal body weight/litter, or external, visceral or skeletal malformations

NOAEL is the highest dose tested

Drinking water: < 0.6 mg/L NaF

Feed: 12.4 mg per kg fluoride

Heindel et al. (1996)
Total F intake (water and feed)a: 1, 4.0, 9.3, 13.2 13.2 mg F /kg/da
Rabbit, New Zealand White rabbits, 26/group

GD 6 through 19

Investigations were done on GD 30

Sodium fluoride (DW)

 < 0.6, 100, 200, 400 NaFa: 0, 10.3, 18.1, 29.2

 ≥ 400 mg/L NaF

29 mg NaF/kg/da

Maternal exposure to NaF during organogenesis did not significantly affect the frequency of postimplantation loss, mean fetal body weight/litter, or external, visceral or skeletal malformations

NOAEL is the highest dose tested

Drinking water: < 0.6 mg/L NaF

Feed: 15.6 mg per kg fluoride

Heindel et al. (1996)
Total F intake (water and feed)a: 0.8, 5.8, 8.8, 13.7 13.7 mg F /kg/da
Rat, CD, 35–37/group

GD 0 through GD 20

Investigations were done on GD 20

Sodium fluoride (DW)

0, 10, 25, 100, 175, 250 NaFa: 0, 1.4, 3.9, 15.6, 24.7, 25.1

175 mg/L NaF

24.7 mg NaF/kg/da

250 mg/L

25.1 mg NaF/kg/da

Fetal growth, number of external anomalies in fetuses, development of specific bones, including sternebrae were not affected by NaF

A significant increase in the average number of fetuses with three or more skeletal variations was observed in the 250 mg/L group

The number of litters with fetuses with three or more skeletal variations was increased in the 250 mg/L group (not statistically significant)

Water consumption in the 175- and 250-mg/L groups was significantly less than that of the control females. The daily amount of NaF ingested was less than expected at the two higher dose levels

Feed: 7.95 mg/kg fluoride

Control: Aqua Cool Ultra Pure water

Collins et al. (1995)
Fa: 0, 0.6, 1.8, 7.1, 11.2, 11.4 11.2 mg F– /kg/da 11.4 mg F /kg/da

Rat, CD,

48/sex/group

Continuously during three generations. F0 rats were treated for 10 weeks and mated within groups

Investigations of F0, F1 and F2 fetuses were done on GD 20

Sodium fluoride (DW)

0, 25, 100, 175 or 250 NaFa: 0, 3.4, 12.4–13.2, 18.8–19.3, 25.8–28.0

175 mg/L NaF

18.8–19.3 mg NaF/kg/d

250 mg/L NaF

25.8–28.0 mg NaF/kg/d

Sodium fluoride in drinking water at 175 mg/L produced no compound-related effects. Numbers of corpora lutea, implants, viable fetuses and fetal morphological development were similar in all groups. No dose-related anomalies in internal organs were observed in F2 fetuses

Ossification of the hyoid bone of F2 fetuses was significantly decreased at 250 mg/L (considered as LOAEL)

Feed: 7.95 mg/kg fluoride

Concentration of fluoride in the Pico system treated water: < 0.2 mg/L

Collins et al. (2001b)
Fa: 0, 1.5, 5.6–6.0, 8.5–8-7, 11.7–12.7 8.5–8.7 mg F /kg/d 11.7–12.7 mg F /kg/d

DW drinking water, GD gestation day, NaF sodium fluoride

aAs reported by the authors of the study